BSE Live
Oct 07, 16:01Prev. Close
72.20
Open Price
73.13
Bid Price (Qty.)
71.01 (50)
Offer Price (Qty.)
72.20 (2659)
NSE Live
Oct 08, 10:17Prev. Close
70.66
Open Price
72.98
Bid Price (Qty.)
71.10 (20)
Offer Price (Qty.)
72.40 (19)
Balance Sheet of Krebs Biochemicals & Industries (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 18.00 | 16.63 | 13.74 | 13.74 | 13.06 | |
Total Share Capital | 18.00 | 16.63 | 13.74 | 13.74 | 13.06 | |
Reserves and Surplus | -50.65 | -30.92 | -31.52 | -12.27 | -14.78 | |
Total Reserves and Surplus | -50.65 | -30.92 | -31.52 | -12.27 | -14.78 | |
Total Shareholders Funds | -25.00 | -14.29 | -17.78 | 1.48 | 1.96 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 65.51 | 50.23 | 51.66 | 42.79 | 71.05 | |
Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Long Term Liabilities | 49.69 | 49.29 | 47.50 | 43.27 | 0.00 | |
Long Term Provisions | 0.47 | 2.27 | 2.21 | 2.82 | 4.14 | |
Total Non-Current Liabilities | 115.66 | 101.79 | 101.37 | 88.88 | 75.19 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade Payables | 22.65 | 21.46 | 17.76 | 10.99 | 12.37 | |
Other Current Liabilities | 19.65 | 32.74 | 23.99 | 19.86 | 15.60 | |
Short Term Provisions | 0.84 | 0.66 | 0.53 | 0.87 | 0.25 | |
Total Current Liabilities | 43.13 | 54.86 | 42.28 | 31.72 | 28.22 | |
Total Capital And Liabilities | 133.80 | 142.37 | 125.88 | 122.08 | 105.36 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 103.37 | 99.08 | 98.93 | 98.57 | 44.38 | |
Intangible Assets | 1.92 | 2.18 | 1.84 | 3.60 | 0.00 | |
Capital Work-In-Progress | 2.35 | 1.63 | 2.19 | 3.50 | 10.54 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 109.48 | 104.75 | 104.51 | 105.68 | 60.00 | |
Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 1.31 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 2.17 | |
Other Non-Current Assets | 5.46 | 6.64 | 4.13 | 3.43 | 32.48 | |
Total Non-Current Assets | 114.94 | 111.39 | 108.64 | 109.10 | 95.97 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 15.00 | 8.96 | 11.73 | 5.45 | 5.64 | |
Trade Receivables | 0.20 | 2.91 | 0.32 | 1.59 | 0.03 | |
Cash And Cash Equivalents | 0.17 | 17.32 | 0.42 | 0.12 | 0.27 | |
Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 3.46 | |
OtherCurrentAssets | 3.49 | 1.78 | 4.77 | 5.81 | 0.00 | |
Total Current Assets | 18.86 | 30.98 | 17.24 | 12.97 | 9.39 | |
Total Assets | 133.80 | 142.37 | 125.88 | 122.08 | 105.36 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 4.84 | 5.95 | 5.95 | 6.38 | 4.61 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 0.75 | 0.75 | 1.58 | 0.00 | 0.00 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | -- | 0.43 | 1.31 | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
22.08.2025
Krebs Biochem Standalone June 2025 Net Sales at Rs 5.48 crore, down 57.48% Y-o-Y
05.02.2025
Krebs Biochem Standalone December 2024 Net Sales at Rs 11.47 crore, down 11.64% Y-o-Y
12.11.2024
Krebs Biochem Standalone September 2024 Net Sales at Rs 12.86 crore, down 13.67% Y-o-Y
08.08.2024
Krebs Biochem Standalone June 2024 Net Sales at Rs 12.89 crore, up 21.81% Y-o-Y